The Tisch Cancer Institute

Research output

Research output per year 1949 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

• 1275855 Citations
• 487 h-index
• 7399 Article
• 1139 Review article
• 423 Comment/debate
• 266 Editorial
• 657 More
  • 251 Letter
  • 239 Chapter
  • 113 Short survey
  • 19 Foreword/postscript
  • 18 Conference contribution
  • 10 Book
  • 6 Conference article
  • 1 Paper

Research output per year

Research output per year

Search results

• 2023

  Erratum: Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements (Communications biology (2022) 5 1 (1295))

  Kimmerling, R. J., Stevens, M. M., Olcum, S., Minnah, A., Vacha, M., LaBella, R., Ferri, M., Wasserman, S. C., Fujii, J., Shaheen, Z., Sundaresan, S., Ribadeneyra, D., Jayabalan, D. S., Agte, S., Aleman, A., Criscitiello, J. A., Niesvizky, R., Luskin, M. R., Parekh, S., Rosenbaum, C. A., & 2 othersTamrazi, A. & Reid, C. A., 6 Jan 2023, In: Communications Biology. 6, 1, p. 15 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

• Materialism meets transcendence

  Krauss, R. S., 6 Jan 2023, In: Science. 379, 6627, p. 36 1 p.

  Research output: Contribution to journal › Comment/debate

• Tumour antigen spreading mediated by vaccine-boosted CAR T cells

  Mateus-Tique, J. & Brown, B., Jan 2023, In: Nature Reviews Immunology. 23, 1, p. 7 1 p.

  Research output: Contribution to journal › Comment/debate
• 2022

  An Urgent Need for Guidelines for Telemedicine Use

  Lin, J. J., Horowitz, C. R. & Ancker, J. S., 2022, (Accepted/In press) In: Journal of General Internal Medicine.

  Research output: Contribution to journal › Comment/debate

  Open Access

• Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer (Nature Communications, (2020), 11, 1, (733), 10.1038/s41467-019-13824-9)

  PCAWG-Structural Variation Working Group & PCAWG Consortium, Dec 2022, In: Nature Communications. 13, 1, 7574.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • telomeres 100%
  • genome 76%
  • document markup languages 70%
  • footprints 66%
  • Telomere 64%

• Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig (Nature Communications, (2020), 11, 1, (731), 10.1038/s41467-020-14352-7)

  PCAWG Evolution and Heterogeneity Working Group & PCAWG Consortium, Dec 2022, In: Nature Communications. 13, 1, 7567.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • genome 100%
  • document markup languages 91%
  • mutations 89%
  • cancer 71%
  • Communication 69%

• Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x)

  Marron, T. U., Galsky, M. D., Taouli, B., Fiel, M. I., Ward, S., Kim, E., Yankelevitz, D., Doroshow, D., Guttman-Yassky, E., Ungar, B., Mehandru, S., Golas, B. J., Labow, D., Sfakianos, J., Nair, S. S., Chakravarty, D., Buckstein, M., Song, X., Kenigsberg, E., Gnjatic, S., & 6 othersBrown, B. D., Sparano, J., Tewari, A., Schwartz, M., Bhardwaj, N. & Merad, M., Aug 2022, In: Nature Medicine. 28, 8, p. 1723 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Drug Discovery 100%
  • Names 92%
  • Medicine 70%
  • Clinical Trials 63%
  • Drug 51%

• Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns (Nature Communications, (2020), 11, 1, (728), 10.1038/s41467-019-13825-8)

  PCAWG Tumor Subtypes and Clinical Translation Working Group & PCAWG Consortium, Dec 2022, In: Nature Communications. 13, 1, 7573.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Deep Learning 100%
  • genome 94%
  • passengers 93%
  • document markup languages 86%
  • mutations 84%

• Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower (Nature Communications, (2020), 11, 1, (734), 10.1038/s41467-019-13929-1)

  PCAWG Drivers and Functional Interpretation Working Group & PCAWG Consortium, Dec 2022, In: Nature Communications. 13, 1, 7571.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • impact tests 100%
  • genome 79%
  • cancer 71%
  • Communication 69%
  • communication 63%

• Author Correction: Fundamental immune–oncogenicity trade-offs define driver mutation fitness (Nature, (2022), 606, 7912, (172-179), 10.1038/s41586-022-04696-z)

  Hoyos, D., Zappasodi, R., Schulze, I., Sethna, Z., de Andrade, K. C., Bajorin, D. F., Bandlamudi, C., Callahan, M. K., Funt, S. A., Hadrup, S. R., Holm, J. S., Rosenberg, J. E., Shah, S. P., Vázquez-García, I., Weigelt, B., Wu, M., Zamarin, D., Campitelli, L. F., Osborne, E. J., Klinger, M., & 10 othersRobins, H. S., Khincha, P. P., Savage, S. A., Balachandran, V. P., Wolchok, J. D., Hellmann, M. D., Merghoub, T., Levine, A. J., Łuksza, M. & Greenbaum, B. D., 16 Jun 2022, In: Nature. 606, 7914, p. E5

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Mutation 100%
  1 Scopus citations

• Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer (Nature Cancer, (2022), 3, 8, (927-931), 10.1038/s43018-022-00400-2)

  Spring, L. M., Han, H., Liu, M. C., Hamilton, E., Irie, H., Santa-Maria, C. A., Reeves, J., Pan, P., Shan, M., Tang, Y., Graham, J. R., Hazard, S., Ellisen, L. W. & Isakoff, S. J., Sep 2022, In: Nature Cancer. 3, 9, p. 1138 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • niraparib 100%
  • Ovarian Neoplasms 49%
  • Reading 47%
  • Breast Neoplasms 34%
  • Neoplasms 17%

• Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations (Nature Communications, (2020), 11, 1, (736), 10.1038/s41467-019-13885-w)

  PCAWG Transcriptome Working Group, PCAWG Structural Variation Working Group & PCAWG Consortium, Dec 2022, In: Nature Communications. 13, 1, 7572.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • genome 100%
  • Gene Rearrangement 89%
  • genes 89%
  • cancer 71%
  • Communication 69%

• Author Correction: Precise quantification of bacterial strains after fecal microbiota transplantation delineates long-term engraftment and explains outcomes (Nature Microbiology, (2021), 6, 10, (1309-1318), 10.1038/s41564-021-00966-0)

  Aggarwala, V., Mogno, I., Li, Z., Yang, C., Britton, G. J., Chen-Liaw, A., Mitcham, J., Bongers, G., Gevers, D., Clemente, J. C., Colombel, J. F., Grinspan, A. & Faith, J., May 2022, In: Nature Microbiology. 7, 5, p. 736 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Fecal Microbiota Transplantation 100%
  • Microbiology 73%
  1 Scopus citations

• Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes (Nature Communications, (2020), 11, 1, (729), 10.1038/s41467-020-14367-0)

  PCAWG Drivers and Functional Interpretation Working Group & PCAWG Consortium, Dec 2022, In: Nature Communications. 13, 1, 7566.

  Research output: Contribution to journal › Comment/debate

  Open Access

• Author Correction: Inferring structural variant cancer cell fraction (Nature Communications, (2020), 11, 1, (730), 10.1038/s41467-020-14351-8)

  PCAWG Evolution and Heterogeneity Working Group & PCAWG Consortium, Dec 2022, In: Nature Communications. 13, 1, 7568.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • genome 100%
  • cancer 71%
  • Communication 69%
  • document markup languages 68%
  • communication 63%

• Author Correction: Integrative pathway enrichment analysis of multivariate omics data (Nature Communications, (2020), 11, 1, (735), 10.1038/s41467-019-13983-9)

  PCAWG Drivers and Functional Interpretation Working Group & PCAWG Consortium, Dec 2022, In: Nature Communications. 13, 1, 7570.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • genome 100%
  • document markup languages 91%
  • cancer 71%
  • Communication 69%
  • communication 63%

• Cancer vaccines

  Schiller, J. T., Lowy, D. R., Frazer, I. H., Finn, O. J., Vilar, E., Lyerly, H. K., Gnjatic, S., Zaidi, N., Ott, P. A., Balachandran, V. P., Dietrich, P. Y., Migliorini, D., Vonderheide, R. H. & Domchek, S. M., 13 Jun 2022, In: Cancer Cell. 40, 6, p. 559-564 6 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Cancer Vaccines 100%
  • Vaccines 61%
  • Pandemics 43%
  • Antigens 26%
  3 Scopus citations

• Can THEM6 targeting stop resistance to prostate cancer treatment?

  Chattopadhyay, M. & Germain, D., 7 Mar 2022, In: EMBO Molecular Medicine. 14, 3, e15504.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Prostatic Neoplasms 100%
  • Unfolded Protein Response 78%
  • Endoplasmic Reticulum 60%
  • Androgens 57%
  • Castration 34%

• CD8⁺ T cells: An ineffective armor against prolonged COVID-19 in cancer patients

  Van Oekelen, O. & Parekh, S., 19 Jul 2022, In: Cell Reports Medicine. 3, 7, 100695.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • T-Lymphocytes 100%
  • Cell- and Tissue-Based Therapy 76%
  • B-Lymphocytes 62%
  • Viruses 53%
  • Neoplasms 52%

• Circling back to PTEN: Fumarate inhibits canonical tumor suppressor

  Claridge, S. E. & Hopkins, B. D., 7 Apr 2022, In: Molecular Cell. 82, 7, p. 1244-1245 2 p.

  Research output: Contribution to journal › Comment/debate

  • Fumarates 100%
  • Phosphatidylinositol 3-Kinases 70%
  • Post Translational Protein Processing 36%
  • Neoplasms 22%
  • Glucose 22%

• Correction: The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals (Clinical Proteomics, (2022), 19, 1, (34), 10.1186/s12014-022-09371-z)

  The Mount Sinai COVID-19 Biobank Team, Dec 2022, In: Clinical Proteomics. 19, 1, 40.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Beckmann Reaction 100%
  • Names 60%
  • Sex Characteristics 59%
  • Proteomics 58%
  • Publications 52%

• Correction: High-resolution transcriptomics informs glial pathology in human temporal lobe epilepsy (Acta Neuropathologica Communications, (2022), 10, 1, (149), 10.1186/s40478-022-01453-1)

  Pai, B., Tome‑Garcia, J., Cheng, W. S., Nudelman, G., Beaumont, K. G., Ghatan, S., Panov, F., Caballero, E., Sarpong, K., Marcuse, L., Yoo, J., Jiang, Y., Schaefer, A., Akbarian, S., Sebra, R., Pinto, D., Zaslavsky, E. & Tsankova, N. M., Dec 2022, In: Acta neuropathologica communications. 10, 1, 171.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Temporal Lobe Epilepsy 100%
  • Neuroglia 75%
  • Publications 71%
  • Communication 64%
  • Pathology 54%

• Corrigendum: Modeling Circadian Phototransduction: Quantitative Predictions of Psychophysical Data (Front. Neurosci., (2021), 15, (615322), 10.3389/fnins.2021.615322)

  Rea, M. S., Nagare, R. & Figueiro, M. G., 18 Feb 2022, In: Frontiers in Neuroscience. 16, 849800.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Light Signal Transduction 100%
  1 Scopus citations

• Dark genome, bright ideas: Recent approaches to harness transposable elements in immunotherapies

  Reid Cahn, A., Bhardwaj, N. & Vabret, N., 8 Aug 2022, In: Cancer Cell. 40, 8, p. 792-797 6 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • DNA Transposable Elements 100%
  • Immunotherapy 68%
  • Genome 52%
  • Human Genome 27%
  • Neoplasms 25%

• Erratum: Author Correction: Brain aging is faithfully modelled in organotypic brain slices and accelerated by prions (Communications biology (2022) 5 1 (557))

  Liu, Y., Senatore, A., Sorce, S., Nuvolone, M., Guo, J., Gümüş, Z. H. & Aguzzi, A., 20 Jun 2022, In: Communications Biology. 5, 1, p. 609 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

• Erratum: Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European journal of human genetics : EJHG (2022) 30 3 (349-362))

  gemo study collaborators, GC-HBOC Study Collaborators, EMBRACE Collaborators, OPAL Study Group, AOCS Group, kconFab Investigators, HEBON Investigators, OCAC Consortium & CIMBA Consortium, 1 May 2022, In: European Journal of Human Genetics. 30, 5, p. 630-631 2 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

• Erratum to “Effect of Simulation-based Training on Surgical Proficiency and Patient Outcomes: A Randomised Controlled Clinical and Educational Trial” [Eur Urol 2022;81:385–393] (European Urology (2022) 81(4) (385–393), (S0302283821021333), (10.1016/j.eururo.2021.10.030))

  SIMULATE Trial Group, Dec 2022, In: European Urology. 82, 6, p. e179

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Simulation Training 100%
  • Urology 83%
  • Confusion 82%
  • Emotions 59%
  • Randomized Controlled Trials 50%

• Food for Thought: Consumption of a High-Fat Diet in Combination With Antibiotics Results in Early Inflammatory Changes in the Gastrointestinal Tract

  Gold, S. L., Faith, J. & Ungaro, R., Jan 2022, In: Gastroenterology. 162, 1, p. 341-343 3 p.

  Research output: Contribution to journal › Comment/debate

• Guidance for Use and dosing of Selinexor in Multiple Myeloma in 2021: Consensus From International Myeloma Foundation Expert Roundtable

  Nooka, A. K., Costa, L. J., Gasparetto, C. J., Richardson, P. G., Siegel, D. S., Chari, A., Lentzsch, S., Jagannath, S. & Mikhael, J., Jul 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, 7, p. e526-e531

  Research output: Contribution to journal › Comment/debate

  • selinexor 100%
  • Multiple Myeloma 53%
  • exportin 1 protein 23%
  • Dexamethasone 18%
  • Tumor Suppressor Proteins 18%
  2 Scopus citations

• JAK Inhibitors in the Treatment of Myelofibrosis

  Levavi, H., Hoffman, R. & Marcellino, B. K., Jul 2022, In: Clinical Advances in Hematology and Oncology. 20, 7, p. 456-468 13 p.

  Research output: Contribution to journal › Comment/debate

  • Janus Kinase Inhibitors 100%
  • Primary Myelofibrosis 89%
  • Splenomegaly 53%
  • Extramedullary Hematopoiesis 34%
  • Drug and Narcotic Control 27%
  2 Scopus citations

• MDS/AML with del5q: An acquired “laminopathy”?

  Papapetrou, E. P., 7 Apr 2022, In: Cell Stem Cell. 29, 4, p. 498-499 2 p.

  Research output: Contribution to journal › Comment/debate

  • lamin B1 100%
  • Neutrophils 46%
  • Stem Cells 44%
  • Genes 24%
  • Neoplasms 19%

• Metformin and Cancer: Is This the End?

  Gallagher, E. J., Kase, N. G., Bickell, N. A. & LeRoith, D., Aug 2022, In: Endocrine Practice. 28, 8, p. 832-834 3 p.

  Research output: Contribution to journal › Comment/debate

• Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery

  Marron, T. U., Galsky, M. D., Taouli, B., Fiel, M. I., Ward, S., Kim, E., Yankelevitz, D., Doroshow, D., Guttman, E., Ungar, B., Mehandru, S., Golas, B. J., Labow, D., Sfakianos, J., Nair, S. S., Chakravarty, D., Buckstein, M., Song, X., Kenigsberg, E., Gnjatic, S., & 6 othersBrown, B. D., Sparano, J., Tewari, A., Schwartz, M., Bhardwaj, N. & Merad, M., Apr 2022, In: Nature Medicine. 28, 4, p. 626-629 4 p.

  Research output: Contribution to journal › Comment/debate
  1 Scopus citations

• Not just neighbours: positive feedback between tumour-associated macrophages and exhausted T cells

  Lubitz, G. S. & Brody, J. D., Jan 2022, In: Nature Reviews Immunology. 22, 1, p. 3 1 p.

  Research output: Contribution to journal › Comment/debate
  3 Scopus citations

• Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2 (Nature, (2022), 602, 7897, (487-495), 10.1038/s41586-021-04352-y)

  Thorne, L. G., Bouhaddou, M., Reuschl, A. K., Zuliani-Alvarez, L., Polacco, B., Pelin, A., Batra, J., Whelan, M. V. X., Hosmillo, M., Fossati, A., Ragazzini, R., Jungreis, I., Ummadi, M., Rojc, A., Turner, J., Bischof, M. L., Obernier, K., Braberg, H., Soucheray, M., Richards, A., & 23 othersChen, K. H., Harjai, B., Memon, D., Hiatt, J., Rosales, R., McGovern, B. L., Jahun, A., Fabius, J. M., White, K., Goodfellow, I. G., Takeuchi, Y., Bonfanti, P., Shokat, K., Jura, N., Verba, K., Noursadeghi, M., Beltrao, P., Kellis, M., Swaney, D. L., García-Sastre, A., Jolly, C., Towers, G. J. & Krogan, N. J., 14 Apr 2022, In: Nature. 604, 7905, p. E14

  Research output: Contribution to journal › Comment/debate

  Open Access

• RASopathy mutations open new insights into the mechanism of BRAF activation

  Dar, A. C. & Brady, D. C., 17 Nov 2022, In: Molecular Cell. 82, 22, p. 4192-4193 2 p.

  Research output: Contribution to journal › Comment/debate

  • Mutation 100%
  • Cysteine 84%

• Regression of Fibrosis Following Hepatitis C Eradication

  Friedman, S. L., Oct 2022, In: Gastroenterology and Hepatology. 18, 10, p. 599-601 3 p.

  Research output: Contribution to journal › Comment/debate

• Ruxolitinib in patients with polycythemia vera with hydroxyurea resistance or intolerance

  Venugopal, S. & Mascarenhas, J., Jul 2022, In: The Lancet Haematology. 9, 7, p. e462-e463

  Research output: Contribution to journal › Comment/debate

• Statistical advising: Professional development opportunities for the biostatistician

  LeBlanc, M., Rueegg, C. S., Bekiroğlu, N., Esterhuizen, T. M., Fagerland, M. W., Falk, R. S., Frøslie, K. F., Graf, E., Heinze, G., Held, U., Holst, R., Lange, T., Mazumdar, M., Myrberg, I. H., Posch, M., Sergeant, J. C., Vach, W., Vance, E. A., Weedon-Fekjær, H. & Zucknick, M., 28 Feb 2022, In: Statistics in Medicine. 41, 5, p. 847-859 13 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

• The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute

  de Andrade, K. C., Lee, E. E., Tookmanian, E. M., Kesserwan, C. A., Manfredi, J. J., Hatton, J. N., Loukissas, J. K., Zavadil, J., Zhou, L., Olivier, M., Frone, M. N., Shahzada, O., Longabaugh, W. J. R., Kratz, C. P., Malkin, D., Hainaut, P. & Savage, S. A., May 2022, In: Cell Death and Differentiation. 29, 5, p. 1071-1073 3 p.

  Research output: Contribution to journal › Comment/debate
  7 Scopus citations
• 2021

  An Interview with Adolfo Garcia-Sastre, PhD

  Garcia-Sastre, A., Jun 2021, In: Journal of Interferon and Cytokine Research. 41, 6, p. 203-204 2 p.

  Research output: Contribution to journal › Comment/debate

• A proposal for risk-based and strategy-adapted de-escalation in human papillomavirus-positive oropharyngeal squamous cell carcinoma

  Wotman, M. T., Miles, B. A., Bakst, R. L. & Posner, M. R., 1 Dec 2021, In: Cancer. 127, 23, p. 4330-4338 9 p.

  Research output: Contribution to journal › Comment/debate
  3 Scopus citations

• Author Correction: A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response (Nature Genetics, (2021), 53, 10, (1504-1516), 10.1038/s41588-021-00935-7)

  NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, Dec 2021, In: Nature Genetics. 53, 12, p. 1722 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Seoul 100%
  • HIV 53%
  • Republic of Korea 46%
  • Population 30%
  • Bioengineering 25%

• Author Correction: Untargeted high-resolution paired mass distance data mining for retrieving general chemical relationships (Communications Chemistry, (2020), 3, 1, (157), 10.1038/s42004-020-00403-z)

  Yu, M. & Petrick, L., Dec 2021, In: Communications Chemistry. 4, 1, 40.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Flavin Mononucleotide 100%
  • Data Mining 81%
  • Mining 76%
  • Molecular weight 75%
  • data mining 71%
  1 Scopus citations

• Author Correction: Sampling the host response to SARS-CoV-2 in hospitals under siege (Nature Medicine, (2020), 26, 8, (1157-1158), 10.1038/s41591-020-1004-3)

  The Mount Sinai COVID-19 Biobank Team, Mar 2021, In: Nature Medicine. 27, 3, p. 560 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Stevens Reaction 100%
  • SARS Virus 93%
  • Sampling 52%
  • Error 47%
  • Medicine 46%

• Author Correction: Inherited causes of clonal haematopoiesis in 97,691 whole genomes (Nature, (2020), 586, 7831, (763-768), 10.1038/s41586-020-2819-2)

  NHLBI Trans-Omics for Precision Medicine Consortium, 25 Mar 2021, In: Nature. 591, 7851, p. E27

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Hematopoiesis 100%
  • Genome 62%
  • Medical Oncology 54%
  • Computational Biology 43%
  • Neoplasms 14%
  2 Scopus citations

• Author Correction: Trained immunity, tolerance, priming and differentiation: distinct immunological processes (Nature Immunology, (2021), 22, 1, (2-6), 10.1038/s41590-020-00845-6)

  Divangahi, M., Aaby, P., Khader, S. A., Barreiro, L. B., Bekkering, S., Chavakis, T., van Crevel, R., Curtis, N., DiNardo, A. R., Dominguez-Andres, J., Duivenvoorden, R., Fanucchi, S., Fayad, Z., Fuchs, E., Hamon, M., Jeffrey, K. L., Khan, N., Joosten, L. A. B., Kaufmann, E., Latz, E., & 24 othersMatarese, G., van der Meer, J. W. M., Mhlanga, M., Moorlag, S. J. C. F. M., Mulder, W. J. M., Naik, S., Novakovic, B., O’Neill, L., Ochando, J., Ozato, K., Riksen, N. P., Sauerwein, R., Sherwood, E. R., Schlitzer, A., Schultze, J. L., Sieweke, M. H., Benn, C. S., Stunnenberg, H., Sun, J., van de Veerdonk, F. L., Weis, S., Williams, D. L., Xavier, R. & Netea, M. G., Jul 2021, In: Nature Immunology. 22, 7, p. 928 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Allergy and Immunology 100%
  • Names 88%
  • Immunity 76%
  4 Scopus citations

• AUTHOR REPLY

  Shukla, D., Simma-Chiang, V., Kyprianou, N., Tewari, A. K. & Lundon, D. J., Nov 2021, In: Urology. 157, p. 70 1 p.

  Research output: Contribution to journal › Comment/debate

• Community Case Study of Naloxone Distribution by Hospital-Based Harm Reduction Program for People Who Use Drugs in New York City

  Riazi, F., Toribio, W., Irani, E., Hughes, T. M., Huxley-Reicher, Z., McBratney, E., Vu, T., Sigel, K. & Weiss, J. J., 7 Jul 2021, In: Frontiers in Sociology. 6, 619683.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • drug use 100%
  • outpatient clinic 38%
  • staff 34%
  • Healthcare 32%
  • free care 23%

• Correction to: EGFR/Ras-induced CCL20 production modulates the tumour microenvironment (British Journal of Cancer, (2020), 123, 6, (942-954), 10.1038/s41416-020-0943-2)

  Hippe, A., Braun, S. A., Oláh, P., Gerber, P. A., Schorr, A., Seeliger, S., Holtz, S., Jannasch, K., Pivarcsi, A., Buhren, B., Schrumpf, H., Kislat, A., Bünemann, E., Steinhoff, M., Fischer, J., Lira, S. A., Boukamp, P., Hevezi, P., Stoecklein, N. H., Hoffmann, T., & 9 othersAlves, F., Sleeman, J., Bauer, T., Klufa, J., Amberg, N., Sibilia, M., Zlotnik, A., Müller-Homey, A. & Homey, B., 26 Oct 2021, In: British Journal of Cancer. 125, 9, p. 1318 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Tumor Microenvironment 100%
  • Internet 92%
  • Neoplasms 31%